News

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...
The public-private pilot aims to improve the detection and identification of harmful algae blooms and support water safety across Finland using cutting-edge Finnish hyperspectral satellite data and AI ...